Zhengye Biotechnology Holding Ltd stock is traded at $1.38, with a volume of 25,673. It is up +0.73% in the last 24 hours and up +15.97% over the past month. Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
Previous Close:
$1.37
Open:
$1.39
24h Volume:
25,673
Relative Volume:
0.44
Market Cap:
$65.40M
Revenue:
$16.18M
Net Income/Loss:
-$11.58M
P/E Ratio:
-
EPS:
-$0.2056
Net Cash Flow:
$98,700
1W Performance:
-3.50%
1M Performance:
+15.97%
6M Performance:
+58.62%
1Y Performance:
-35.21%
1-Day Range:
$1.32$1.44
1-Week Range:
$1.25$1.44
52-Week Range:
$0.6155$8.01
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS